Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Randomised Blinded Investigation of Therapeutic Ablation Versus Cardioversion for Persistent Atrial Fibrillation

NCT03907982 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT03907982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Randomised Blinded Investigation of Therapeutic Ablation Versus Cardioversion for Persistent Atrial Fibrillation
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
April 26, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmia, persistent atrial fibrillation